# K133614: Aleutian Ibf System

- Pathway: 510(k) (Traditional)
- Applicant: K2m, Inc.
- Decided: Apr 3, 2014 after 129 days
- Product code: MAX (Intervertebral Fusion Device With Bone Graft, Lumbar)
- Device class: 2
- Regulation: 21 CFR 888.3080
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 13 generations back to K841189 (1984). 65 ancestors in all.
527 later devices descend from it; 14 cite it directly.
0 of 593 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K082698: Aleutian Ibf System, K2m, Inc. (2009) Summary page 2.
- K101302: Aleutian Ibf System, K2m, Inc. (2010) Summary page 2.
- K103169: Aleuttian, K2m, Inc. (2011) Summary page 2.
- K110843: Aleutian Spacer System, K2m, Inc. (2011)
- K113138: Aleutian System, K2m, Inc. (2012) Summary page 2.
- K130699: Aleutian Spinal System, K2m, Inc. (2013) Summary page 2.

## Most influential descendants
- K150481: Cascadia Interbody System (2015), 459 descendants of its own
- K160125: Cascadia Interbody System (2016), 315 descendants of its own
- K163230: NuVasive Modulus XLIF Interbody System (2017), 276 descendants of its own
- K143126: Renovis S141 Lumbar Interbody Cage System (2015), 237 descendants of its own
- K151374: NuVasive MLX-Medial Lateral Expandable Lumbar Interbody System, NuVasive AP Expandable XLIF System (2015), 235 descendants of its own

## Indications for use
When used as a cervical intervertebral body fusion device, the ALEUTIAN implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients. Cervical IBF implants are intended for use at one level in the cervical spine, from C2 to TI, for the treatment of cervical disc disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies). The cervical device is intended to be used in patients who have had six weeks of non-operative treatment. When used as a lumbar intervertebral body fusion device, the ALEUTIAN implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients. The lumbar IBE implants are intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to SI1, for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is intended to be used in patients who have had six months of non-operative treatment. When used as vertebral body replacement devices the ALEUTIAN implants are indicated for use in the thoracolumbar spine (TI to LS) for partial replacement (i.e., partial vertebrectomy) of a diseased vertebral body, resected or excised for the treatment of tumors or trauma/fracture in order to achieve anterior decompression of the spinal cord and neural tissues, and to restore the height of a collapsed vertebral body. The ALEUTIAN implants are designed to restore the biomechanical integrity of the anterior, middle, and posterior spinal column even in the absence of fusion for a prolonged period. For all the above indications the ALEUTIAN implants are intended to be used with supplemental internal fixation appropriate for the implanted level, including K2M Pedicle Screw and Hook Systems, and K2M Spinal Plate Systems.

Source page: https://510kreport.com/device/K133614
Methodology: https://510kreport.com/methodology